Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis.

Despite its broad spectrum, conventional amphotericin B (AB) is associated with serious adverse events. Lipid-based formulations may offer safer options. We aimed to synthesize the evidence of efficacy and safety of AB formulations.